Clinical trial comparing the safety and immunogenicity of two combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus (DTaP-IPV) vaccines administered to healthy children at 2, 3½, and 16 months of age.

Trial Profile

Clinical trial comparing the safety and immunogenicity of two combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus (DTaP-IPV) vaccines administered to healthy children at 2, 3½, and 16 months of age.

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Jan 2013

At a glance

  • Drugs DTaP poliovirus vaccine; Hib vaccine conjugate
  • Indications Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
  • Focus Pharmacodynamics; Registrational
  • Most Recent Events

    • 26 Sep 2008 Primary endpoint 'Seroprotection rate' has been met, according to published results.
    • 26 Sep 2008 Results have been published in the September issue of Vaccine.
    • 02 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top